Table 3.
White blood cell subsets and platelets at baseline and 45 and 90 days.
| Measure | Reference range | Time | RBAC | Placebo |
|---|---|---|---|---|
| White blood cells (103/μL)∗ | 4.3–10.3 | Baseline | 6.7 ± 2.7 (3.6, 13.8) | 5.5 ± 1.1 (2.5, 6.4) |
| 45 days | 6.5 ± 2.5 (3.8, 12) | 5.8 ± 1.5 (4.2, 9) | ||
| 90 days | 6.7 ± 2.8 (3.4, 13.4) | 6 ± 1.6 (2.8, 8.4) | ||
| Neutrophils (%) | 41–73 | Baseline | 53.1 ± 9.2 (37.7, 65.7) | 56.7 ± 6.1 (45, 67.6) |
| 45 days | 50.8 ± 10.2 (25.8, 64.5) | 56.4 ± 5.9 (45.8, 65.3) | ||
| 90 days | 48.5 ± 10.6 (25.5, 66.9) | 56.6 ± 6.1 (47.6, 64.8) | ||
| Lymphocytes (%) | 19.4–44.9 | Baseline | 36.8 ± 7.5 (26, 51.2) | 32.7 ± 5.7 (22.9, 42.6) |
| 45 days | 37.9 ± 9.6 (23.6, 61.8) | 32.8 ± 6.5 (20.2, 42) | ||
| 90 days | 38.6 ± 9.6 (22.2, 60.1) | 32.4 ± 4.9 (29.4, 39) | ||
| Neutrophil/lymphocyte ratio | None | Baseline | 1.5 ± 0.6 (0.7, 2.5) | 1.8 ± 0.5 (1.1, 2.5) |
| 45 days | 1.5 ± 0.6 (0.4, 2.7) | 1.8 ± 0.6 (1.1, 3.0) | ||
| 90 days | 1.4 ± 0.7 (0.4, 3.0) | 1.8 ± 0.4 (1.2, 2.3) | ||
| Monocytes (%)+ | 5.1–10.9 | Baseline | 7.3 ± 2.1 (3.5, 11.8) | 7.3 ± 4 (3.6, 18.5) |
| 45 days | 7.8 ± 1.2 (5.9, 10.1) | 8.1 ± 3.3 (5.5, 16.5) | ||
| 90 days | 9.1 ± 1.3 (6.9, 11.3) | 8.1 ± 4.4 (4.5, 19.4) | ||
| Eosinophils (%)^∗ | 0.9–6.0 | Baseline | 2.5 ± 1.3 (1.2, 4.9) | 2.9 ± 1.4 (1.1, 5.5) |
| 45 days | 3 ± 1.2 (2.1, 5.5) | 2.2 ± 1.1 (0.5, 4.1) | ||
| 90 days | 3.3 ± 1.5 (1.6, 6) | 2.2 ± 1.2 (0.8, 4.4) | ||
| Platelets (103/μL)∗ | 156–373 | Baseline | 254.8 ± 90.5 (180, 511) | 196.9 ± 61.9 (81, 292) |
| 45 days | 225.6 ± 46.7 (170, 311) | 194.3 ± 65.3 (55, 267) | ||
| 90 days | 229.5 ± 51.8 (176, 351) | 210.4 ± 91.6 (65, 398) |
Values are mean ± standard deviation (minimum, maximum). ∗Percent change difference (p < 0.05) from baseline to 90 days; +percent change difference (p < 0.05) from 45 days to 90 days; ^percent change difference (p < 0.05) from baseline to 45 days.